Test Price
30,000 AEDโ Home Collection Available
Whole Genome Genetic Mapping Test in UAE โ Comprehensive SNP Analysis at DNA Labs UAE
Executive Summary & Core Metrics
Next-Gen Precision Genomic Screening
- โ 99.9% Diagnostic Sensitivity โ ISO 9001:2015 Certified Genome-Wide SNP Microarray Analysis (Cert: INT/EGQ/2509DA/3139) covering over 700,000 markers across the entire genome.
- โ Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM, including weekends.
- โ Clinical Guidance: Mandatory post-test telephonic interpretation by DHA-licensed Consultant Medical Geneticist ensuring actionable understanding and appropriate referrals.
- โ Insurance Direct Billing: Instant eligibility verification via WhatsApp at +971 54 548 8731 (all major UAE insurers).
- โ Price: 30,000 AED inclusive of full bioinformatics analysis, clinical curation, and physician consultation.
Test Overview & Methodology
Whole Genome Genetic Mapping (WGM) analyzes over 700,000 SNPs using high-density microarray technology to reveal predispositions across 2,000+ genetic disorders, pharmacogenomic profiles, and ancestry markers. This comprehensive test employs the Infinium Global Screening Array-24 v3.0 platform with CNV-Partition and long-range phasing algorithms, delivering the highest resolution genomic backbone available for clinical screening in the UAE.
| Attribute | Our Test (WGM) | Closest Alternative (WES) |
|---|---|---|
| Precision / Coverage | 2.8M probes; whole genome backbone | Exonic regions only (~1%) |
| Methodology | SNP Genotyping Microarray + CNV analysis | Next-Generation Sequencing (exome capture) |
| Report Speed | 8 weeks (double bioinformatics verification) | 10โ14 weeks |
| Clinical Utility | Pediatric, adult-onset, carrier, PGx, wellness | Mainly rare Mendelian disorders |
Methodology Note: Updated to high-density Infinium Global Screening Array-24 v3.0 with CNV-Partition and long-range phasing algorithms, harmonized against DHA genomic medicine specifications. All bioinformatics pipelines adhere to ACMG/AMP variant interpretation guidelines.
Physician Insight & Safety Protocols
โWhole genome mapping uncovers predispositions, not certainties. As a Consultant Medical Geneticist, I emphasize that every report requires contextual review with your primary physician. At DNA Labs UAE, we ensure no result is released without a thorough counseling session, respecting the emotional and psychological dimensions of genetic knowledge. Our dual-bioinformatics validation pipeline guarantees 99.9% analytic accuracy before clinical interpretation begins.โ
โ Lina Osama Zaki Quteineh, Consultant Medical Genetics (DHA Registration ID: 9294403)
Medication & Therapy Advisory
โ ๏ธ Critical Advisory
Do not discontinue or modify any prescribed medication or therapy based solely on genetic test findings without consulting your treating physician. Pharmacogenomic results indicate metabolic profiles, not clinical indications for dosage adjustment. Always correlate with comprehensive clinical assessment by a qualified medical professional.
Exclusion Criteria & Safety Considerations
๐จ Patient Suitability & Emergency Red Flags
- Exclusion: Active hemolytic anemia, recent blood transfusion (< 4 weeks), or bone marrow transplant recipient โ may compromise germline DNA purity and yield inaccurate results.
- Exclusion: Inability to provide mandated Genome Mapping Consent Form (Form 26) signed by an adult legal guardian for minors โ requires dual parental consent and DHA judicial approval.
- Emergency Red Flag: If report reveals a pathogenic variant in BRCA1/2, LDLR, or RYR2, immediate cardiology or oncology referral is indicated. Do not delay clinical evaluation.
- Emergency Red Flag: Suicide risk or severe psychological distress upon discussion of hereditary conditions โ contact UAE mental health hotline (800-4673) alongside genetic counseling services.
- Child Protection: Testing of minors requires explicit consent from both parents or legal guardians, DHA judicial approval, and mandatory post-test familial counseling in accordance with UAE Federal laws.
Patient FAQ & Clinical Guidance
1. What is the turnaround time and process for whole genome mapping?
Your fully interpreted whole genome report is delivered in 8 weeks from sample collection. The process includes sample accessioning, DNA extraction from peripheral whole blood, microarray hybridization on the Infinium GSA-24 v3.0 platform, high-resolution scanning, dual independent bioinformatics pipelines (including CNV-Partition and long-range phasing), followed by physician-led clinical curation and a mandatory telephonic results disclosure session with our Consultant Medical Geneticist.
2. Is any special preparation required before providing a sample?
No fasting or special preparation is required. Simply provide 3 mL of whole blood collected in an EDTA lavender-top tube. Our VIP Mobile Phlebotomy service will collect the sample at your home or office between 8 AM and 11 PM daily. The sample is transported under strict temperature-controlled cold-chain conditions to our ISO-certified laboratory. Avoid freezing the sample and ensure the tube is gently inverted 8โ10 times after collection to prevent clotting.
3. Can children be tested, and what are the legal requirements?
Yes, minors can be tested under strict regulatory oversight. UAE law requires explicit written consent from both parents or legal guardians using the authorized Genome Mapping Consent Form (Form 26). A DHA judicial review is mandatory prior to sample collection, and post-test familial genetic counseling must be conducted. The test is not recommended for children under 2 years unless clinically indicated due to developmental concerns.
4. How is my genetic data protected under UAE law?
Your genomic data is protected under Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic data is encrypted and stored on ISO 27001-certified servers within the UAE. Samples are de-identified after analysis to prevent re-identification. We never share data without explicit written consent, and you retain the right to request data deletion at any time, subject to regulatory retention requirements.
5. What does the 30,000 AED price include?
The price of 30,000 AED includes the complete end-to-end service: VIP mobile phlebotomy home collection, high-density microarray analysis covering 700,000+ SNPs, dual bioinformatics validation pipelines, CNV analysis, comprehensive clinical interpretation by our Consultant Medical Geneticist, a detailed PDF report with actionable recommendations, and a mandatory telephonic counseling session. Insurance direct billing is available for major UAE insurers โ verify eligibility via WhatsApp at +971 54 548 8731 before booking.
UAE Regulatory & Data Privacy Adherence
Legal & Compliance Framework
DNA Labs UAE operates under the strictest UAE data protection and healthcare regulations. All genetic testing procedures, data handling, and patient communication protocols comply with:
- Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) โ governing collection, processing, storage, and transfer of personal genetic data.
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields โ regulating electronic health records and telehealth platforms used for counseling.
- Federal Decree-Law No. 4 of 2016 on Medical Liability โ ensuring clinical safety, informed consent, and patient rights throughout the testing journey.
- DHA Health Regulation Standards โ all testing is conducted under DHA Facility License Number 1143, with mandatory reporting of clinically significant findings.
Our laboratory is ISO 9001:2015 certified (Cert: INT/EGQ/2509DA/3139) and follows CAP/CLIA-equivalent quality standards for all genomic analyses.
Clinical & Logistical Metadata
| Test Name | Whole Genome Genetic Mapping (WGM) |
| Price (AED) | 30,000 |
| Turnaround Time | 8 weeks from sample collection (including bioinformatics validation and clinical curation) |
| Sample Type / Matrix | Peripheral Whole Blood (3 mL in EDTA lavender-top tube) |
| Methodology Used | High-Density SNP Microarray โ Infinium Global Screening Array-24 v3.0 with CNV-Partition and long-range phasing algorithms |
| ICD-10-CM Code | Z13.89 (Encounter for screening for other disorder) |
| LOINC Code | 81247-9 (Whole genome analysis of Blood or Tissue by Array-based genotyping method) |
| DHA Facility License & Laboratory Address | DHA Facility License Number: 1143 โ Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE โ DNA Labs UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians